Meet the Program Commitee for 2022!

Petra Doerr, PHARMD, RPH • Director
European Directorate for the Quality of Medicines and Healthcare (EDQM), France

Sini Eskola, MPHARM, MS, MSC • Head of International Regulatory Policy and Innovation
Takeda, Belgium

Marco Greco, PHD • President
European Patients' Forum, Belgium

Sabine Haubenreisser, PHD, MSC • Principal Scientific Administrator, Stakeholders and Communication Division
European Medicines Agency, Netherlands

Niklas Hedberg, MPHARM • HTACG Co-Chair & Chief Pharmacist
Dental and Pharmaceutical Benefits Agency, TLV, Sweden

Volker Liebenberg • Chief Medical Officer
Elypta, Sweden

Alan Morrison, PHD • Vice President Regulatory Affairs Intl
MSD, United Kingdom

Karen A Noonan, MA • Senior Vice President, Global Regulatory Policy
Association of Clinical Research Organizations (ACRO), United States

Sibilia Quilici • Executive Director
Vaccines Europe, Belgium

Tim Buchanan • Senior Director, Clinical Lead, Tau, Neurology Patient Value Unit
UCB Biopharma, Belgium

Manuel Haas, PHARMD, MSC • Executive Director - Regulatory Affairs Europe
MSD UK, United Kingdom

Rebecca Stanbrook, RPH • EFPIA ICH E6(R3) Expert Working Group Member
RESaltas GmbH, Switzerland

Matt Popkin, PHD • Senior Director, CMC Excellence, Global Regulatory Affairs
GSK, United Kingdom

Diane Wilkinson, PHD, RPH • Executive Director, Global CMC Regulatory Affairs
AstraZeneca, United Kingdom

Thomas Brookland, MSC • Regulatory Science and Policy Lead
F. Hoffmann-La Roche Ltd, Switzerland

Douglas Gregory • Senior Director, Government Affairs Strategy
Bristol Myers Squibb, Belgium

Ronnie Mundair • Regional Labelling Head - Canada and LATAM - Senior Director
Pfizer, United Kingdom

Rodrigo Palacios, MBA • Senior Director, Technical Regulatory Policy
F. Hoffmann-La Roche Ltd., Switzerland

Henrik K. Nielsen, PHD, MBA, MSC • Vice President
Novo Nordisk A/S, Denmark

Isabelle Stoeckert, PHARMD, PMP • Independent Regulatory Science Expert
Independent, Germany

Álmath Spooner, PHD • Director of Regulatory Policy and Intelligence
AbbVie, Ireland

Raphael Van Eemeren • EU QPPV Senior Director, Global Patient Safety
Amgen AB, Sweden

Alison Cave, PHD • Chief Safety Officer
Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom

Patrice Verpillat, DrMed, MD, PHD, MPH • Head of Real World Evidence
European Medicines Agency, Netherlands

Rick Vreman • Patient Access Manager
Roche, Netherlands

Nadege Le Roux, PHD • Regulatory Policy Senior Director
Bristol Myers Squibb, Switzerland

Andras Incze • Founder & CEO, Akceso Advisors AG, Switzerland
University Lecturer Healthcare Management, B-W State University, Germany, Switzerland

Piers Mahon • Senior Principal and European Leader
Oncology Evidence Networks, IQVIA, United Kingdom

Bettina Ryll • Member of the First EU Cancer Mission Board
MPNE, Vision Zero Cancer, Sweden

プログラム委員会